THUMPD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.341400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.026000E-01
Normal-vs-Stage2
8.529600E-01
Normal-vs-Stage3
2.197800E-01
Normal-vs-Stage4
1.165230E-01
Stage1-vs-Stage2
6.520600E-01
Stage1-vs-Stage3
1.536560E-01
Stage1-vs-Stage4
1.744210E-01
Stage2-vs-Stage3
1.264580E-01
Stage2-vs-Stage4
4.906000E-02
Stage3-vs-Stage4
1.681560E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.532600E-01
Normal-vs-AfricanAmerican
3.207800E-01
Normal-vs-Asian
9.590200E-01
Caucasian-vs-AfricanAmerican
1.841430E-01
Caucasian-vs-Asian
6.383600E-01
AfricanAmerican-vs-Asian
3.695200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.781800E-01
Normal-vs-Female
7.854400E-01
Male-vs-Female
7.143800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.035400E-01
Normal-vs-Age(41-60Yrs)
9.960600E-01
Normal-vs-Age(61-80Yrs)
7.423400E-01
Normal-vs-Age(81-100Yrs)
9.463600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.582800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.671000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.223600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.156600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.690000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.378800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.089800E-01
Normal-vs-Daily Drinker
6.000800E-01
Normal-vs-Weekly Drinker
7.105000E-01
Normal-vs-Occasional Drinker
9.499000E-01
Normal-vs-Social Drinker
9.380400E-01
Non Drinker-vs-Daily Drinker
4.760200E-01
Non Drinker-vs-Weekly Drinker
6.083800E-01
Non Drinker-vs-Occasional Drinker
8.761000E-01
Non Drinker-vs-Social Drinker
7.208000E-01
Daily Drinker-vs-Weekly Drinker
9.583000E-01
Daily Drinker-vs-Occasional Drinker
3.400400E-01
Daily Drinker-vs-Social Drinker
2.813400E-01
Weekly Drinker-vs-Occasional Drinker
4.903000E-01
Weekly Drinker-vs-Social Drinker
4.282200E-01
Occasional Drinker-vs-Social Drinker
8.010000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.340960E-01
Normal-vs-Grade 2
8.001300E-03
Normal-vs-Grade 3
1.581990E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.183100E-03
Grade 1-vs-Grade 3
1.046230E-02
Grade 1-vs-Grade 4
1.340960E-01
Grade 2-vs-Grade 3
8.775200E-01
Grade 2-vs-Grade 4
8.001300E-03
Grade 3-vs-Grade 4
1.581990E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.101200E-01
Normal-vs-NonDiabetic
9.370200E-01
Diabetic-vs-NonDiabetic
1.775610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.695800E-01
Normal-vs-NoPancreatitis
7.792000E-01
Pancreatitis-vs-NoPancreatitis
2.273600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.811800E-01
Normal-vs-N1
8.053400E-01
N0-vs-N1
4.654800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.845000E-01
Normal-vs-TP53-NonMutant
8.270200E-01
TP53-Mutant-vs-TP53-NonMutant
1.049580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
